Patient Guide: A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 27 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05181618
Status: ACTIVE_NOT_RECRUITING
Condition: Severe Hemophilia A, Moderate Hemophilia A
Phase: PHASE4

Where You Can Participate

This study is available at 27 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Miami, Florida
  • • Oklahoma City, Oklahoma
  • • And 24 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis - Join Clinical Trial NCTNCT05181618

How to Join This Clinical Trial - NCTNCT05181618

Learn how to participate in this PHASE4 trial studying an investigational therapy for Severe Hemophilia A, Moderate Hemophilia A. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Severe Hemophilia A, Moderate Hemophilia A. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Severe Hemophilia A, Moderate Hemophilia A
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05181618 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 27 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90007 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33136 - United States

Status: Contact for availability

Clinical Research Site

Oklahoma City, Oklahoma 73104 - United States

Status: Contact for availability

Clinical Research Site

Campinas, São Paulo 13083-878 - Brazil

Status: Contact for availability

Clinical Research Site

Ribeirão Preto, São Paulo 14051-140 - Brazil

Status: Contact for availability

Clinical Research Site

Hamilton, Ontario L9H 2B7 - Canada

Status: Contact for availability

Clinical Research Site

Berlin, 13353 - Germany

Status: Contact for availability

Clinical Research Site

Bonn, 53127 - Germany

Status: Contact for availability

Clinical Research Site

Budapest, 1134 - Hungary

Status: Contact for availability

Clinical Research Site

Napoli, Campania 80131 - Italy

Status: Contact for availability

And 17 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Severe Hemophilia A, Moderate Hemophilia A:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships